Anthera (ANTH) Prices 33M Offering at $1/Share

Article Stock Quotes (1) Comments (0)

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) today announced the pricing of an underwritten public offering of 33 million shares of its common stock, offered at a price of $1.00 per share. The Company estimates that the gross proceeds from the offering, before deducting underwriting discounts and commissions and other estimated offering expenses payable by Anthera, will be $33 million. The offering is expected to close on or about July 24, 2012, subject to customary closing conditions. In addition, Anthera has granted the underwriters a 30-day option to purchase up to an additional 4.95 million shares of common stock to cover over-allotments, if any. The Company intends to use the net proceeds from the offering for general corporate purposes.

Piper Jaffray & Co. and Leerink Swann LLC are acting as joint book-running managers in the offering. Canaccord Genuity is acting as lead manager in the offering. Summer Street Research Partners is acting as co-manager in the offering.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• BioLineRx (BLRX) Enters $20M ATM Offering w/ Stifel
• Walgreen (WAG), Boots Cleared for AmerisourceBergen (ABC) Investment
• Hess (HES), Elliott to End Proxy Contest; Three Elliott Nominees Will be Added

Create E-mail Alert Related Categories

Corporate News, Equity Offerings

Related Entities

Piper Jaffray, Canaccord Genuity

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?